Elsevier Announces the Launch of a New Journal: Geoderma Regional
Amsterdam, March 10, 2014
The new journal welcomes both original research articles and reviews on every aspect of soil science. Geoderma Regional will focus on specifically regional studies; in the meantime its mother journal, Geoderma, will continue to focus on soil science on a global scale.
“The world is facing many global issues and soil is a critical component in their understanding and management. Most of the global issues require research that leads to solutions at national and regional levels,” says the Editor-in-Chief, Alfred Hartemink of the University of Wisconsin-Madison, USA. “Geoderma Regional includes soil studies that increase understanding and scientific knowledge in all regions of the world. The journal embraces fundamental and applied studies of every sub-discipline in soil science. We look forward receiving papers resulting from regional soil studies.”
“We are very excited about the launch of Geoderma Regional as it is our first journal to include reference of the region through article geotagging: authors will be asked to include the location of the experiment and soil type studied, with this information it will be possible to visualize and easily search for studies by location and soil type,” explains Gilles Jonker, Executive Publisher at Elsevier.
Geoderma Regional follows an article-based publishing model,allowing for immediate publication of the final version of a paper without waiting for other articles to be compiled into a full issue.
The first published articles are expected to become available for access online on ScienceDirect in June.
For more information or submit an article, please visit: www.elsevier.com/locate/geodrs
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+31 20 485 2744